Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-11

Clinical Trial Update: Residual Inhibition of 40 Hz Burst Sound in Tinnitus Patients [NA]

View source ↗

Summary

This clinical trial evaluated residual inhibition of tinnitus using a 40 Hz burst sound. The study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Eye & ENT Hospital of Fudan University | Conditions: Tinnitus | NA | Status: COMPLETED